Nationwide estimates for the UK and Denmark of the number of IS cases potentially occurring among patients with AF who had discontinued OAC therapy at the time of stroke
| IS cases in last full year of follow-up† who were OAC discontinuers at the time of stroke | Population of IMRD-UK/RSD aged 20–89 years | Nationwide population aged 20–89 years* | Multiplicative factor | Estimated number of IS cases nationwide among OAC discontinuers | |
| UK | 63 | 2 125 080 | 49 948 645 | 23.5 (49 948 645/2 125 080) | 1481 (63×23.5) |
| Denmark | 42 | 932 769 | 4 430 000 | 4.7 (4 430 000/932 769) | 198 (42×4.7) |
*Data for first quarter of 2018 used from Statistics Denmark.
†2017 UK, 2018 Denmark.
AF, atrial fibrillation; IMRD-UK, IQVIA Medical Research Data-UK; IS, ischaemic stroke; OAC, oral anticoagulant; RSD, Region of Southern Denmark.;